A First-In-Human Study of ARO-033 in Adult Participants

NCT07662096 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

84

Enrollment

INDUSTRY

Sponsor class

Conditions

Age-related Macular Degeneration

Interventions

DRUG: ARO-033
DRUG: Placebo

Sponsor

Arrowhead Pharmaceuticals